medimix.be
Sep 19, 2024, 14:21
Guilherme Nader Marta: Evergreen study led by Diogo Martins Branco
Guilherme Nader Marta, Oncology Fellow at Jules Bordet Institute, shared on X:
“EVERGREEN study led by Diogo Martins Branco.
A quasi-experimental analysis of >200 pts, showed that Everolimus+ET increased PFS (aHR 0.68, CI 0.47-0.99) vs ET alone after progression on CDK4/6i
EVE had higher efficacy when combined with AI, increased BMI, IDC, and longer prior CDK4/6 Treatment.”
Source: Guilherme Nader Marta/X
-
ESMO 2024 Congress
September 13-17, 2024
-
ASCO Annual Meeting
May 30 - June 4, 2024
-
Yvonne Award 2024
May 31, 2024
-
OncoThon 2024, Online
Feb. 15, 2024
-
Global Summit on War & Cancer 2023, Online
Dec. 14-16, 2023
Dec 21, 2024, 19:39
Dec 21, 2024, 19:21
Dec 21, 2024, 19:19
Dec 21, 2024, 19:18
Dec 21, 2024, 18:59
Dec 21, 2024, 18:57
Dec 21, 2024, 18:54